x
Norris Cotton Cancer CenterNorris Cotton Cancer Center
In This Section

Recently Opened Clinical Trials for October 2014

Angeline Andrew
Assistant Professor
Cancer Epidemiology
NCI grant
MicroRNA dysregulation and bladder cancer prognosis

Camilo Fadul
Professor
Immunology and Cancer Immunotherapy
NCI
Phase I/comparative randomized Phase II trial of TRC105 plus bevacizumab versus bevacizumab in bevacizumab-naïve patients with recurrent glioblastoma multiforme

Alliance – NCI Cooperative Group
A Phase III randomized, double-blind placebo controlled study of armodafinil (Nuvigil®) to reduce cancer-related fatigue in patients with high grade glioma

Peter Kaufman
Associate Professor
Molecular Therapeutics
Eisai
A randomized Phase III trial of eribulin compared to standard weekly paclitaxel as first- or second-line therapy for locally recurrent or metastatic breast cancer

J Marc Pipas
Professor
Molecular Therapeutics
ECOG
A randomized Phase II study of temozolomide or temozolomide and capecitabine in patients with advanced pancreatic neuroendocrine tumors

0